DUBAI-FUTURE-FOUNDATION
17.6.2024 11:14:26 CEST | Business Wire | Press release
Dubai is increasingly becoming a global center for artificial intelligence. To this end, the metropolis of the day after tomorrow on the Gulf has pledged to train one million people in AI prompting over the next three years with Dubai Future Foundation overseeing the AI prompt program.. It is the first program of its kind in the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240613025960/en/
Omar Al Olama, the UAE´s Minister of State for AI, Digital Economy, and Remote Work Applications. (Photo: Business Wire)
“We want to be the most future-ready city and continue to prepare for the AI era by developing expertise and skills that support global technological change and put Dubai at the forefront of innovation,” said the Chairman of the Board of Trustees of the Dubai Future Foundation (DFF), Crown Prince Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, at the launch of the 'One Million AI Prompters' initiative in Dubai.
The United Arab Emirates, in which Dubai is the most important emirate alongside Abu Dhabi, is preparing for the post-oil era and wants to transform itself from an oil state into an AI power. By 2031, 40 percent of the gross domestic product is to be generated with artificial intelligence. To this end, the UAE is investing billions, has appointed the world's first Minister of State for AI, is attracting scientists to the Gulf, and is providing massive support for start-ups.
AI prompt engineering is critical to getting the best out of generative AI. It involves understanding the capabilities, limitations, and nuances of AI models and is predicted to be one of the most important skills in the future workplace.
‘One Million AI Prompters’, the first-of-its-kind prompt engineering initiative, that prepares expertise and competencies in AI prompt engineering, which involves crafting precise and effective instructions for AI systems to achieve desired outcomes in various tasks, ranging from generating creative content to solving complex challenges.
"We want to show people that there is a full spectrum of use cases. Whether you are technical or non-technical, you can utilize these tools,” said Omar Al Olama, the UAE´s Minister of State for AI, Digital Economy, and Remote Work Applications. He also highlighted the importance of developing practical prompt engineering skills, as these are crucial for the workforce of tomorrow and for enhancing quality of life through AI. Al Olama was appointed as the world's first AI Minister of State in the UAE in 2017.
World Championship in AI Prompt in Dubai
To launch the ‘One Million AI Prompters’ initiative, the first Global Prompt Engineering Championship was recently held in Dubai. Participants competed in categories beyond traditional coding, such as literature and art, highlighting the broad applicability of AI tools. In AI, a prompt refers to a specific request to a language model (e.g. ChatGPT or others) that can provide the user with an answer or solution.
The Global Prompt Engineering Championship received thousands of entries from around 100 countries. Thirty finalists from 13 countries qualified to come to Dubai to compete for the title of best prompt engineer in the competition's three categories. The winners were Australian Megan Fowkes in the art category Indian Ajay Cyril, 33, for coding, and Aditya Nair, 34, in literature. The Dubai Centre for Artificial Intelligence (DCAI) provided one million dirhams, approximately 273,000 US dollars, in prize money for the three winners.
Global competition around the United Arab Emirates
The UAE is increasingly being courted as a strategic partner by global tech giants. Microsoft, Google, and IBM already took part in the first championship with workshops. However, other companies and countries have also expressed interest in AI collaborations. There has been an AI university in the UAE since 2019 and the sovereign wealth fund Mubadala has set up a $100 billion AI fund.
Microsoft recently invested $1.5 billion in G42, the leading UAE-based artificial intelligence (AI) technology holding company. The US software giant recognizes the Gulf state's leading role in the development of artificial intelligence: “This strategic investment will enhance the UAE’s position as a global AI hub and provide further opportunities for partners and customers to innovate and grow”.
For more information on the Global Prompt Engineering Championship, please visit:
https://challenge.dub.ai/en/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240613025960/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom